Elizabeth Arden (RDEN) Guides Q2 Lower
Tweet Send to a FriendGet Alerts RDEN Hot Sheet
Price: $48.40 -0.82%
Revenue Growth %: +10.5%
Financial Fact:
Total cost of goods sold: 138.3M
Today's EPS Names:
BORN, EFUT, ZOOM, More
Revenue Growth %: +10.5%
Financial Fact:
Total cost of goods sold: 138.3M
Today's EPS Names:
BORN, EFUT, ZOOM, More
Trade RDEN Now!
Elizabeth Arden, Inc. (Nasdaq: RDEN) sees Q2 net sales in the range of $365 million to $370 million. The Wall Street consensus is $424.5 million.
Elizabeth Arden sees Q2 EPS of $0.57 to $0.61 per diluted share, or $0.72 to $0.76 per diluted share, excluding the estimated unfavorable impact of foreign currency of approximately $0.15 per diluted share. This compares to prior guidance of $1.00 to $1.10 per diluted share, excluding an unfavorable impact of foreign currency of $0.11 per diluted share. The Wall Street consensus was $0.94.
Elizabeth Arden sees Q2 EPS of $0.57 to $0.61 per diluted share, or $0.72 to $0.76 per diluted share, excluding the estimated unfavorable impact of foreign currency of approximately $0.15 per diluted share. This compares to prior guidance of $1.00 to $1.10 per diluted share, excluding an unfavorable impact of foreign currency of $0.11 per diluted share. The Wall Street consensus was $0.94.
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Natus Medical (BABY) Tops Q1 EPS by 4c; Nudges FY13 EPS Outlook Higher
- Hercules (HERO) to Divest Inland Fleet in $45M Deal; Sees Impact
Create E-mail Alert Related Categories
Guidance, Hot List
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
